Reuters logo
BRIEF-Celyad announces registration of the first patient in the Belgian THINK trial
January 5, 2017 / 6:19 AM / 9 months ago

BRIEF-Celyad announces registration of the first patient in the Belgian THINK trial

Jan 5 (Reuters) - Celyad SA :

* Celyad announces registration of the first patient in the Belgian THINK trial

* A first colorectal cancer patient has been registered at institut Jules Bordet

* CAR-T NKR-2 processing started yesterday at Celyad’s manufacturing facility, in Mont-Saint-Guibert

* Blood was collected from this patient and first CAR-T NKR-2 dose level infusion (3x108 cells) is expected in January 2017 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below